eli lilly and company retatrutide Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://t.co/YZ6AWs9FqL Eli Lilly's retatrutide hits Phase

If you are navigating decisions about metabolic health, hormonal optimization, or recovery, the most durable foundation is not a single compound it is a clear picture of your underlying biology

RRM2 promotes liver metastasis of pancreatic cancer by stabilizing YBX1 and activating the TGF-beta pathway

Mistake #5: Eating Too Much Volume Why it's a problem: GLP-1s increase feelings of fullness and slow digestion

10.1152/physrev.1992.72.1.101 Physiol

Unlike other weight-loss injections, retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously, whereas typical injections target one or two of these receptors